56741-98-1 Usage
Molecular structure
2-(5-bromo-4-oxo-6-phenyl-1,4-dihydropyrimidin-2-yl)-1-hydroxy-1-oxodiazanium consists of a dihydropyrimidine ring with a bromine atom, a phenyl group, and a hydroxyl-diazanium group attached.
Dihydropyrimidine ring
The compound contains a dihydropyrimidine ring, which is a six-membered heterocyclic ring with two nitrogen atoms and one oxygen atom.
Bromine atom
A bromine atom is attached to the dihydropyrimidine ring, which may influence the compound's reactivity, stability, and physical properties.
Phenyl group
A phenyl group is also attached to the dihydropyrimidine ring, which can affect the compound's steric properties and electronic effects.
Hydroxyl-diazanium group
The presence of a hydroxyl-diazanium group (-OH-N2+) suggests that the compound may have properties related to both a hydroxyl group and a diazanium cation.
Potential applications
The specific chemical and biological properties of this compound would need to be further investigated to understand its potential applications in various fields, such as pharmaceuticals or materials science.
Structural similarity to dihydropyrimidine
The compound is structurally similar to dihydropyrimidine, with the addition of the bromine atom and the phenyl group, which may result in altered properties and reactivity compared to the parent compound.
Need for further investigation
The specific chemical and biological properties of 2-(5-bromo-4-oxo-6-phenyl-1,4-dihydropyrimidin-2-yl)-1-hydroxy-1-oxodiazanium are not fully known and require further research to determine its potential applications and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 56741-98-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,7,4 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 56741-98:
(7*5)+(6*6)+(5*7)+(4*4)+(3*1)+(2*9)+(1*8)=151
151 % 10 = 1
So 56741-98-1 is a valid CAS Registry Number.